American Health and Drug Benefits

Scope & Guideline

Transforming drug benefits management with rigorous scholarship.

Introduction

Immerse yourself in the scholarly insights of American Health and Drug Benefits with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1942-2962
PublisherENGAGE HEALTHCARE COMMUNICATIONS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2009 to 2023
AbbreviationAM HEALTH DRUG BENEF / Am. Health Drug Benefits
Frequency9 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address318 CLEVELAND AVE, HIGHLAND PARK, NJ 08904

Aims and Scopes

The journal 'American Health and Drug Benefits' focuses on the intersection of healthcare economics, policy, and pharmaceutical benefits, aiming to provide valuable insights into cost-effective treatment strategies and the management of healthcare resources.
  1. Healthcare Economics:
    The journal emphasizes research on the economic aspects of healthcare, including cost-effectiveness analyses and budget impact assessments for medications and treatments.
  2. Drug Utilization and Management:
    It covers studies related to the utilization patterns of drugs, including opioid management and medication therapy management, highlighting strategies to optimize drug use.
  3. Chronic Disease Management:
    The journal frequently publishes articles addressing the management of chronic diseases, including cancer and COPD, focusing on treatment patterns and healthcare costs.
  4. Health Disparities:
    Research on health disparities, particularly in medication adherence and access to care among different racial and ethnic groups, is a critical area of focus.
  5. Policy and Innovation in Healthcare:
    It explores policy implications and innovative approaches in healthcare delivery, particularly regarding the implementation of biosimilars and the impact of Medicare policies.
The journal has seen a shift towards addressing contemporary challenges in healthcare economics and drug management, reflecting emerging trends in the field.
  1. Real-World Evidence in Treatment Patterns:
    There is an increasing emphasis on real-world studies that analyze treatment patterns and healthcare costs, particularly in chronic conditions, which helps inform policy and practice.
  2. Cost-Effectiveness Analyses:
    Recent publications highlight a growing interest in cost-effectiveness studies for various treatments, signaling a trend towards evidence-based economic evaluations in healthcare.
  3. Integration of Biosimilars in Healthcare:
    The implementation strategies for biosimilars are gaining traction, reflecting a broader trend towards innovative treatment options and cost-containment strategies in the pharmaceutical sector.
  4. Addressing Racial and Ethnic Disparities:
    Research focusing on reducing health disparities, especially through Medicare Part D and medication management, is increasingly relevant, highlighting a commitment to equity in healthcare access.
  5. Impact of COVID-19 on Healthcare Practices:
    The effects of the COVID-19 pandemic on medication adherence and healthcare delivery models are emerging themes, indicating a response to the changing landscape of healthcare.

Declining or Waning

While the journal has a strong focus on various aspects of healthcare economics and drug benefits, some themes have shown a decline in prominence over recent years.
  1. Mental Health in Workplace Settings:
    Topics related to mental illness disclosure and workplace improvements have become less frequent, indicating a potential waning interest in this area within the journal's focus.
  2. Historical Perspectives on Healthcare:
    The exploration of historical narratives, such as the 'Government, Big Pharma, and the People' series, appears to be diminishing, suggesting a shift towards more contemporary issues.
  3. General Health Promotion Among College Students:
    Research specifically targeting health promotion and prescription drug misuse among college students seems to be less prevalent, indicating a decrease in focus on this demographic.

Similar Journals

Health Services Research and Managerial Epidemiology

Transforming healthcare policies with evidence-based findings.
Publisher: SAGE PUBLICATIONS INCISSN: 2333-3928Frequency: 1 issue/year

Health Services Research and Managerial Epidemiology is an esteemed peer-reviewed journal published by SAGE Publications Inc, dedicated to advancing the fields of health services research and epidemiology. With the ISSN 2333-3928, this Open Access journal, available since 2014, aims to foster a deeper understanding of the managerial aspects of epidemiology and its implications for health service delivery. By offering insights into critical healthcare policies and practices, the journal serves as an important resource for researchers, practitioners, and students alike. As of 2023, it is classified in the Q3 quartile for both Epidemiology and Health Policy, ranking within the 31st and 30th percentiles, respectively, in Scopus rankings. The journal’s scope encompasses a wide variety of topics, ranging from health management practices to innovative research methodologies, making it a key platform for disseminating influential work that shapes health policy and public health strategies. Operating out of the United States, at 2455 Teller Rd, Thousand Oaks, CA 91320, it continues to push the boundaries of knowledge in an increasingly vital area of study.

Journal of Managed Care & Specialty Pharmacy

Shaping Health Policy with Impactful Insights
Publisher: ACAD MANAGED CARE PHARMACYISSN: 2376-0540Frequency: 12 issues/year

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.

International Journal of Clinical Pharmacy

Connecting Scholars and Practitioners for a Healthier Tomorrow
Publisher: SPRINGERISSN: 2210-7703Frequency: 6 issues/year

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

Pharmacy Practice-Granada

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Exploring the frontiers of clinical pharmacy and therapeutics.
Publisher: WILEY-HINDAWIISSN: 0269-4727Frequency: 1 issue/year

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Current Oncology

Leading the Charge in Oncology Innovation
Publisher: MDPIISSN: 1198-0052Frequency: 12 issues/year

Current Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Fostering excellence in pharmacy through rigorous scholarship.
Publisher: OXFORD UNIV PRESS INCISSN: 1079-2082Frequency: 24 issues/year

American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.

Integrated Pharmacy Research and Practice

Uniting research and practice to elevate pharmaceutical standards.
Publisher: DOVE MEDICAL PRESS LTDISSN: 2230-5254Frequency: 1 issue/year

Integrated Pharmacy Research and Practice is a peer-reviewed, open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of pharmacy through innovative research and practice. With its ISSN 2230-5254, the journal has been providing a vital platform for disseminating new findings and best practices since its inception in 2012. Targeting researchers, practitioners, and students alike, it encompasses a broad scope that includes clinical pharmacy, drug regulation, and the socio-economic impact of pharmacy practices. Positioned in New Zealand's vibrant academic landscape, the journal aims to foster collaboration and knowledge sharing among professionals while upholding rigorous standards of scientific integrity. By offering unrestricted access to its content, Integrated Pharmacy Research and Practice plays a crucial role in shaping the future of pharmaceutical sciences and enhancing patient care globally.

HOSPITAL PHARMACY

Elevating clinical pharmacy standards through scholarly excellence.
Publisher: SAGE PUBLICATIONS INCISSN: 0018-5787Frequency: 6 issues/year

Hospital Pharmacy is a distinguished journal published by SAGE Publications Inc., dedicated to advancing the field of pharmacy practice within health professions. Established in 1973 and with a commitment to scholarly excellence extending to 2024, the journal aims to provide a platform for research that impacts patient care and medication management. With an impact factor that reflects its contribution to the field, it holds a notable position in Pharmacology and Pharmacy, ranking in the Q3 category in both pharmacology domains and Q2 in the pharmacy category as of 2023. The journal’s commitment to evidence-based practice is evident through its rigorous publication standards, making it an essential resource for researchers, practitioners, and students alike. Though it operates under a subscription model, its vast repository of knowledge facilitates significant advancements in pharmaceutical sciences and clinical pharmacy practices. For those engaged in the healthcare sector, Hospital Pharmacy serves not only as a source of research but also as a catalyst for innovative practices in the pharmacy profession.

JAMA Health Forum

Connecting Experts to Tackle Global Health Challenges
Publisher: AMER MEDICAL ASSOCISSN: 2689-0186Frequency:

Introducing the JAMA Health Forum, a premier journal published by the American Medical Association, dedicated to advancing knowledge in the critical fields of health policy and public health. Since its inception in 2020, this open-access journal has emerged as a leading platform for high-quality research, achieving a distinguished Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health for 2023. With an ISSN of 2689-0186, it provides a vital resource for researchers, policymakers, and students alike, facilitating widespread dissemination of impactful studies that aim to shape health strategies and improve community health outcomes. The JAMA Health Forum not only fosters collaboration among experts but also enhances global discussions on pressing health issues, making it an essential read for anyone involved in health-related research and practice.